Uchiyama T, Broder S, Waldmann TA. "A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells". J Immunol 1981, 126(4):1393–1397. PMID6970774
Waldmann TA, Goldman CK, Bongiovanni KF, Sharrow SO, Davey MP, Cease KB, Greenberg SJ, Longo DL. "Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2". Blood 1988, 72(5): 1805–1816. PMID2846094
Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J, Frank JA, Würfe J, Ohayon J, Waldmann TA, McFarland HF, Martin R. "Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon-beta". Proc Natl Acad Sci USA 2004, 101(23):8705–8708. PMID15161974
Janik JE, Morris JC, O'Mahony D, Pittaluga S, Jaffe ES, Redon CE, Bonner WM, Brechbiel MW, Paik CH, Whatley M, Chen C, Lee-J-H, Fleisher TA, Brown M, White JD, Stewart DM, Fioravanti S, Lee CC, Goldman CK, Bryant BR, Junghans RP, Carrasquillo JA, Worthy TY, Corcoran E, Conlon KC, Waldmann TA. "90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma". Proc Natl Acad Sci USA, 2015, 112(42):13045–13050. PMID26438866
Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. "A lymphokine, provisionally designated interleukin-T, produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells". Proc Natl Acad Sci USA 1994, 91(11):4935–4939. PMID8197160
Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. "The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells". Proc Natl Acad Sci USA 1994, 91(11):4940–4944. PMID8197161
Dubois S, Mariner J, Waldmann TA Tagaya Y. "IL-15R alpha recycles and presents IL-15 in trans to neighboring cells". Immunity 2002, 17(5):537–547. PMID12433361
Conlon KC, Lugli E, Welles HC, Rosenberg SA, Fojo AT, Morris JC, Fleisher TA, Dubois SP, Perera LP, Stewart DM, Goldman CK, Bryant BR, Decker JM, Chen J, Worthy TYA, Figg WD, Sr, Peer CJ, Sneller MC, Lane HC, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA. "Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer". J Clin Oncol. 2015, 33(1):74–82. PMID25403209
Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh SK. "Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice". J Virol. 2007, 81(16):8774–8783. PMID17553867
Poon LLM, Leung YHC, Nicholls JM, Perera P-Y, Lichy JH, Yamamoto M, Waldmann TA, Peiris JSM, Perera LP. "Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice." J Immunol. 2009, 182(5):3063–3071. PMID19234203
Berkowitz JL, Janik JE, Stewart DM, Jaffe ES, Stetler-Stevenson M, Shih JH, Fleisher TA, Turner M, Urquhart NE, Wharfe GH, Figg WD, Peer CJ, Goldman CK, Waldmann TA, Morris JC. "Safety, efficacy and pharmacokinetics/pharmacodynamics, of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma". Clin Immunol. 2014, 155(2):176–187. PMID25267440
Korsmeyer SJ, Arnold A, Bakhshi A, Ravetch JV, Siebenlist U, Hieter PA, Sharrow SO, LeBien TW, Kersey JH, Poplack DG, Leder P, Waldmann TA. "Immunoglobulin gene rearrangement and cell surface antigen expression of acute lymphocyte leukemias of T-cell and B-cell precursor origins". J Clin Invest 1983, 71(2):301–313. PMID6401769
